Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Watson to sell a generic of J&J's Concerta for ADHD

Executive Summary

Watson Laboratories Inc. has signed an exclusive distribution agreement for a generic version of Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals Inc.'s (OMJPI) blockbuster drug Concerta (methylphenidate) extended-release tablets. The product is approved for ADHD in children 6-12 years old and adults up to the age of 65 as part of a program that may include counseling.
Deal Industry
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing
    • Manufacturing or Supply
    • Includes Royalty or Profit Split Information

Related Companies